Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients (RAND)

Clinical Trial ID NCT01195818

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01195818

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002 7.59
2 The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005 6.49
3 Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005 6.14
4 Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2005 3.98
5 Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 1991 2.17
6 Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003 1.96
7 Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 2006 1.94
8 Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 2006 1.92
9 Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982 1.86
10 Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992 1.82
11 Renal myogenic response: kinetic attributes and physiological role. Circ Res 2002 1.74
12 Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006 1.35
13 Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem 2008 1.31
14 A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med 1998 1.16
15 Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000 1.12
16 Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 1998 1.10
17 Elderly survivors with homozygous sickle cell disease. N Engl J Med 2007 1.07
18 Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med 1995 0.95
19 [Guidelines for management of adult sickle cell disease]. Rev Med Interne 2009 0.94
20 Glomerular hyperfiltration in microalbuminuric NIDDM patients. Diabetologia 1996 0.91
21 Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag 2009 0.90
22 51Cr-EDTA measurements of the glomerular filtration rate in patients with sickle cell anaemia and minor renal damage. Nucl Med Commun 2006 0.90
23 Comparison of renal function markers in Kuwaiti patients with sickle cell disease. J Clin Pathol 2006 0.88
24 Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis. Am J Hematol 2008 0.87
Next 100